Huya Bioscience International LLC;Shanghai Institute of Materia Medica, Chinese Academy of Sciences
发明人:
ELLIOTT, GARY T.,WANG, YIPING,BAI, DONGLU
申请号：
PL10832056
公开号：
PL2501380T3
申请日:
2010.11.16
申请国别(地区):
PL
年份:
2016
代理人:
摘要：
A composition comprised of an active agent that is 4-methoxy-N-(3,5-bis-(1-pyrrolidinyl)-4-hydroxy benzyl)benzene sulfonamide or a pharmaceutically acceptable salt thereof is intravenously administered to a subject, substantially evenly over a period of greater than about 15 minutes, to avoid disadvantageous hemodynamic effects, including systemic diastolic and systolic hypotension, to can occur with rapid intravenous or even short-term infusion administration of the active agent.
